nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—ABCB1—Methylprednisolone—psoriatic arthritis	0.0794	0.118	CbGbCtD
Nefazodone—CYP3A7—Dexamethasone—psoriatic arthritis	0.0615	0.0913	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0615	0.0913	CbGbCtD
Nefazodone—ABCB1—Betamethasone—psoriatic arthritis	0.0516	0.0767	CbGbCtD
Nefazodone—ABCB1—Prednisolone—psoriatic arthritis	0.051	0.0756	CbGbCtD
Nefazodone—ABCB1—Prednisone—psoriatic arthritis	0.0481	0.0714	CbGbCtD
Nefazodone—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0476	0.0706	CbGbCtD
Nefazodone—CYP3A5—Dexamethasone—psoriatic arthritis	0.0462	0.0685	CbGbCtD
Nefazodone—CYP3A4—Triamcinolone—psoriatic arthritis	0.0361	0.0535	CbGbCtD
Nefazodone—CYP3A4—Betamethasone—psoriatic arthritis	0.0309	0.0459	CbGbCtD
Nefazodone—CYP3A4—Prednisolone—psoriatic arthritis	0.0305	0.0453	CbGbCtD
Nefazodone—ABCB1—Dexamethasone—psoriatic arthritis	0.03	0.0446	CbGbCtD
Nefazodone—CYP3A4—Prednisone—psoriatic arthritis	0.0288	0.0428	CbGbCtD
Nefazodone—CYP2D6—Dexamethasone—psoriatic arthritis	0.0283	0.042	CbGbCtD
Nefazodone—ABCB1—Methotrexate—psoriatic arthritis	0.0241	0.0358	CbGbCtD
Nefazodone—CYP3A4—Dexamethasone—psoriatic arthritis	0.018	0.0267	CbGbCtD
Nefazodone—Myalgia—Methylprednisolone—psoriatic arthritis	0.000415	0.00127	CcSEcCtD
Nefazodone—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000415	0.00127	CcSEcCtD
Nefazodone—Anxiety—Methylprednisolone—psoriatic arthritis	0.000413	0.00127	CcSEcCtD
Nefazodone—Flushing—Prednisone—psoriatic arthritis	0.000411	0.00126	CcSEcCtD
Nefazodone—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000411	0.00126	CcSEcCtD
Nefazodone—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000411	0.00126	CcSEcCtD
Nefazodone—Discomfort—Triamcinolone—psoriatic arthritis	0.00041	0.00126	CcSEcCtD
Nefazodone—Discomfort—Methylprednisolone—psoriatic arthritis	0.00041	0.00125	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000409	0.00125	CcSEcCtD
Nefazodone—Dry mouth—Triamcinolone—psoriatic arthritis	0.000406	0.00125	CcSEcCtD
Nefazodone—Angioedema—Betamethasone—psoriatic arthritis	0.000405	0.00124	CcSEcCtD
Nefazodone—Angioedema—Dexamethasone—psoriatic arthritis	0.000405	0.00124	CcSEcCtD
Nefazodone—Stomatitis—Methotrexate—psoriatic arthritis	0.000402	0.00123	CcSEcCtD
Nefazodone—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000401	0.00123	CcSEcCtD
Nefazodone—Confusional state—Methylprednisolone—psoriatic arthritis	0.000401	0.00123	CcSEcCtD
Nefazodone—Malaise—Betamethasone—psoriatic arthritis	0.000399	0.00122	CcSEcCtD
Nefazodone—Malaise—Dexamethasone—psoriatic arthritis	0.000399	0.00122	CcSEcCtD
Nefazodone—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000398	0.00122	CcSEcCtD
Nefazodone—Oedema—Triamcinolone—psoriatic arthritis	0.000398	0.00122	CcSEcCtD
Nefazodone—Vertigo—Dexamethasone—psoriatic arthritis	0.000398	0.00122	CcSEcCtD
Nefazodone—Vertigo—Betamethasone—psoriatic arthritis	0.000398	0.00122	CcSEcCtD
Nefazodone—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000397	0.00122	CcSEcCtD
Nefazodone—Syncope—Betamethasone—psoriatic arthritis	0.000397	0.00122	CcSEcCtD
Nefazodone—Syncope—Dexamethasone—psoriatic arthritis	0.000397	0.00122	CcSEcCtD
Nefazodone—Infection—Triamcinolone—psoriatic arthritis	0.000396	0.00121	CcSEcCtD
Nefazodone—Sweating—Methotrexate—psoriatic arthritis	0.000395	0.00121	CcSEcCtD
Nefazodone—Infection—Methylprednisolone—psoriatic arthritis	0.000395	0.00121	CcSEcCtD
Nefazodone—Haematuria—Methotrexate—psoriatic arthritis	0.000393	0.0012	CcSEcCtD
Nefazodone—Shock—Triamcinolone—psoriatic arthritis	0.000392	0.0012	CcSEcCtD
Nefazodone—Insomnia—Prednisolone—psoriatic arthritis	0.000392	0.0012	CcSEcCtD
Nefazodone—Alopecia—Prednisone—psoriatic arthritis	0.000391	0.0012	CcSEcCtD
Nefazodone—Shock—Methylprednisolone—psoriatic arthritis	0.000391	0.0012	CcSEcCtD
Nefazodone—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000389	0.00119	CcSEcCtD
Nefazodone—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000389	0.00119	CcSEcCtD
Nefazodone—Epistaxis—Methotrexate—psoriatic arthritis	0.000389	0.00119	CcSEcCtD
Nefazodone—Paraesthesia—Prednisolone—psoriatic arthritis	0.000389	0.00119	CcSEcCtD
Nefazodone—Tachycardia—Triamcinolone—psoriatic arthritis	0.000389	0.00119	CcSEcCtD
Nefazodone—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000388	0.00119	CcSEcCtD
Nefazodone—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000385	0.00118	CcSEcCtD
Nefazodone—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000384	0.00118	CcSEcCtD
Nefazodone—Convulsion—Dexamethasone—psoriatic arthritis	0.000384	0.00118	CcSEcCtD
Nefazodone—Convulsion—Betamethasone—psoriatic arthritis	0.000384	0.00118	CcSEcCtD
Nefazodone—Hypertension—Betamethasone—psoriatic arthritis	0.000382	0.00117	CcSEcCtD
Nefazodone—Hypertension—Dexamethasone—psoriatic arthritis	0.000382	0.00117	CcSEcCtD
Nefazodone—Myalgia—Dexamethasone—psoriatic arthritis	0.000377	0.00116	CcSEcCtD
Nefazodone—Myalgia—Betamethasone—psoriatic arthritis	0.000377	0.00116	CcSEcCtD
Nefazodone—Anxiety—Dexamethasone—psoriatic arthritis	0.000376	0.00115	CcSEcCtD
Nefazodone—Anxiety—Betamethasone—psoriatic arthritis	0.000376	0.00115	CcSEcCtD
Nefazodone—Discomfort—Betamethasone—psoriatic arthritis	0.000372	0.00114	CcSEcCtD
Nefazodone—Discomfort—Dexamethasone—psoriatic arthritis	0.000372	0.00114	CcSEcCtD
Nefazodone—Haemoglobin—Methotrexate—psoriatic arthritis	0.000372	0.00114	CcSEcCtD
Nefazodone—Hypotension—Methylprednisolone—psoriatic arthritis	0.000371	0.00114	CcSEcCtD
Nefazodone—Pain—Prednisolone—psoriatic arthritis	0.00037	0.00113	CcSEcCtD
Nefazodone—Haemorrhage—Methotrexate—psoriatic arthritis	0.00037	0.00113	CcSEcCtD
Nefazodone—Hepatitis—Methotrexate—psoriatic arthritis	0.00037	0.00113	CcSEcCtD
Nefazodone—Pharyngitis—Methotrexate—psoriatic arthritis	0.000367	0.00113	CcSEcCtD
Nefazodone—Vision blurred—Prednisone—psoriatic arthritis	0.000363	0.00111	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000363	0.00111	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000362	0.00111	CcSEcCtD
Nefazodone—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000361	0.00111	CcSEcCtD
Nefazodone—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000361	0.00111	CcSEcCtD
Nefazodone—Oedema—Dexamethasone—psoriatic arthritis	0.000361	0.00111	CcSEcCtD
Nefazodone—Oedema—Betamethasone—psoriatic arthritis	0.000361	0.00111	CcSEcCtD
Nefazodone—Insomnia—Triamcinolone—psoriatic arthritis	0.00036	0.0011	CcSEcCtD
Nefazodone—Insomnia—Methylprednisolone—psoriatic arthritis	0.000359	0.0011	CcSEcCtD
Nefazodone—Infection—Betamethasone—psoriatic arthritis	0.000359	0.0011	CcSEcCtD
Nefazodone—Infection—Dexamethasone—psoriatic arthritis	0.000359	0.0011	CcSEcCtD
Nefazodone—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000358	0.0011	CcSEcCtD
Nefazodone—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000358	0.0011	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000357	0.00109	CcSEcCtD
Nefazodone—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000357	0.00109	CcSEcCtD
Nefazodone—Visual impairment—Methotrexate—psoriatic arthritis	0.000357	0.00109	CcSEcCtD
Nefazodone—Anaemia—Prednisone—psoriatic arthritis	0.000356	0.00109	CcSEcCtD
Nefazodone—Shock—Betamethasone—psoriatic arthritis	0.000356	0.00109	CcSEcCtD
Nefazodone—Shock—Dexamethasone—psoriatic arthritis	0.000356	0.00109	CcSEcCtD
Nefazodone—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000355	0.00109	CcSEcCtD
Nefazodone—Agitation—Prednisone—psoriatic arthritis	0.000354	0.00109	CcSEcCtD
Nefazodone—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000354	0.00108	CcSEcCtD
Nefazodone—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000354	0.00108	CcSEcCtD
Nefazodone—Tachycardia—Dexamethasone—psoriatic arthritis	0.000353	0.00108	CcSEcCtD
Nefazodone—Tachycardia—Betamethasone—psoriatic arthritis	0.000353	0.00108	CcSEcCtD
Nefazodone—Angioedema—Prednisone—psoriatic arthritis	0.000352	0.00108	CcSEcCtD
Nefazodone—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000351	0.00107	CcSEcCtD
Nefazodone—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00035	0.00107	CcSEcCtD
Nefazodone—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00035	0.00107	CcSEcCtD
Nefazodone—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000349	0.00107	CcSEcCtD
Nefazodone—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000349	0.00107	CcSEcCtD
Nefazodone—Malaise—Prednisone—psoriatic arthritis	0.000348	0.00107	CcSEcCtD
Nefazodone—Vertigo—Prednisone—psoriatic arthritis	0.000346	0.00106	CcSEcCtD
Nefazodone—Syncope—Prednisone—psoriatic arthritis	0.000346	0.00106	CcSEcCtD
Nefazodone—Tinnitus—Methotrexate—psoriatic arthritis	0.000345	0.00106	CcSEcCtD
Nefazodone—Anorexia—Betamethasone—psoriatic arthritis	0.000344	0.00106	CcSEcCtD
Nefazodone—Anorexia—Dexamethasone—psoriatic arthritis	0.000344	0.00106	CcSEcCtD
Nefazodone—Urticaria—Prednisolone—psoriatic arthritis	0.000344	0.00105	CcSEcCtD
Nefazodone—Pain—Triamcinolone—psoriatic arthritis	0.000341	0.00104	CcSEcCtD
Nefazodone—Loss of consciousness—Prednisone—psoriatic arthritis	0.000339	0.00104	CcSEcCtD
Nefazodone—Hypotension—Betamethasone—psoriatic arthritis	0.000338	0.00103	CcSEcCtD
Nefazodone—Hypotension—Dexamethasone—psoriatic arthritis	0.000338	0.00103	CcSEcCtD
Nefazodone—Convulsion—Prednisone—psoriatic arthritis	0.000334	0.00102	CcSEcCtD
Nefazodone—Hypertension—Prednisone—psoriatic arthritis	0.000333	0.00102	CcSEcCtD
Nefazodone—Chills—Methotrexate—psoriatic arthritis	0.000332	0.00102	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000329	0.00101	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000329	0.00101	CcSEcCtD
Nefazodone—Arthralgia—Prednisone—psoriatic arthritis	0.000328	0.00101	CcSEcCtD
Nefazodone—Myalgia—Prednisone—psoriatic arthritis	0.000328	0.00101	CcSEcCtD
Nefazodone—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000328	0.00101	CcSEcCtD
Nefazodone—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000327	0.001	CcSEcCtD
Nefazodone—Anxiety—Prednisone—psoriatic arthritis	0.000327	0.001	CcSEcCtD
Nefazodone—Alopecia—Methotrexate—psoriatic arthritis	0.000327	0.001	CcSEcCtD
Nefazodone—Insomnia—Dexamethasone—psoriatic arthritis	0.000327	0.001	CcSEcCtD
Nefazodone—Insomnia—Betamethasone—psoriatic arthritis	0.000327	0.001	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000325	0.000996	CcSEcCtD
Nefazodone—Paraesthesia—Betamethasone—psoriatic arthritis	0.000324	0.000994	CcSEcCtD
Nefazodone—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000324	0.000994	CcSEcCtD
Nefazodone—Discomfort—Prednisone—psoriatic arthritis	0.000324	0.000994	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000319	0.000978	CcSEcCtD
Nefazodone—Dyspepsia—Betamethasone—psoriatic arthritis	0.000318	0.000975	CcSEcCtD
Nefazodone—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000318	0.000975	CcSEcCtD
Nefazodone—Urticaria—Triamcinolone—psoriatic arthritis	0.000316	0.000969	CcSEcCtD
Nefazodone—Urticaria—Methylprednisolone—psoriatic arthritis	0.000316	0.000967	CcSEcCtD
Nefazodone—Dysgeusia—Methotrexate—psoriatic arthritis	0.000316	0.000967	CcSEcCtD
Nefazodone—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000315	0.000965	CcSEcCtD
Nefazodone—Oedema—Prednisone—psoriatic arthritis	0.000315	0.000964	CcSEcCtD
Nefazodone—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000315	0.000964	CcSEcCtD
Nefazodone—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000314	0.000963	CcSEcCtD
Nefazodone—Decreased appetite—Betamethasone—psoriatic arthritis	0.000314	0.000963	CcSEcCtD
Nefazodone—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000314	0.000963	CcSEcCtD
Nefazodone—Infection—Prednisone—psoriatic arthritis	0.000313	0.000958	CcSEcCtD
Nefazodone—Back pain—Methotrexate—psoriatic arthritis	0.000312	0.000955	CcSEcCtD
Nefazodone—Shock—Prednisone—psoriatic arthritis	0.00031	0.000949	CcSEcCtD
Nefazodone—Pain—Betamethasone—psoriatic arthritis	0.000309	0.000947	CcSEcCtD
Nefazodone—Pain—Dexamethasone—psoriatic arthritis	0.000309	0.000947	CcSEcCtD
Nefazodone—Tachycardia—Prednisone—psoriatic arthritis	0.000307	0.000941	CcSEcCtD
Nefazodone—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000304	0.000932	CcSEcCtD
Nefazodone—Vision blurred—Methotrexate—psoriatic arthritis	0.000304	0.000931	CcSEcCtD
Nefazodone—Anorexia—Prednisone—psoriatic arthritis	0.0003	0.000919	CcSEcCtD
Nefazodone—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000299	0.000916	CcSEcCtD
Nefazodone—Anaemia—Methotrexate—psoriatic arthritis	0.000298	0.000913	CcSEcCtD
Nefazodone—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000298	0.000912	CcSEcCtD
Nefazodone—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000298	0.000912	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000295	0.000905	CcSEcCtD
Nefazodone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000295	0.000905	CcSEcCtD
Nefazodone—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000293	0.000899	CcSEcCtD
Nefazodone—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000293	0.000897	CcSEcCtD
Nefazodone—Malaise—Methotrexate—psoriatic arthritis	0.000291	0.00089	CcSEcCtD
Nefazodone—Vertigo—Methotrexate—psoriatic arthritis	0.00029	0.000887	CcSEcCtD
Nefazodone—Leukopenia—Methotrexate—psoriatic arthritis	0.000288	0.000884	CcSEcCtD
Nefazodone—Urticaria—Dexamethasone—psoriatic arthritis	0.000287	0.00088	CcSEcCtD
Nefazodone—Urticaria—Betamethasone—psoriatic arthritis	0.000287	0.00088	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000287	0.000879	CcSEcCtD
Nefazodone—Dizziness—Prednisolone—psoriatic arthritis	0.000286	0.000878	CcSEcCtD
Nefazodone—Asthenia—Triamcinolone—psoriatic arthritis	0.000286	0.000876	CcSEcCtD
Nefazodone—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000286	0.000875	CcSEcCtD
Nefazodone—Abdominal pain—Betamethasone—psoriatic arthritis	0.000286	0.000875	CcSEcCtD
Nefazodone—Body temperature increased—Betamethasone—psoriatic arthritis	0.000286	0.000875	CcSEcCtD
Nefazodone—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000286	0.000875	CcSEcCtD
Nefazodone—Asthenia—Methylprednisolone—psoriatic arthritis	0.000285	0.000874	CcSEcCtD
Nefazodone—Insomnia—Prednisone—psoriatic arthritis	0.000285	0.000872	CcSEcCtD
Nefazodone—Paraesthesia—Prednisone—psoriatic arthritis	0.000283	0.000866	CcSEcCtD
Nefazodone—Pruritus—Triamcinolone—psoriatic arthritis	0.000282	0.000863	CcSEcCtD
Nefazodone—Cough—Methotrexate—psoriatic arthritis	0.000281	0.000862	CcSEcCtD
Nefazodone—Pruritus—Methylprednisolone—psoriatic arthritis	0.000281	0.000861	CcSEcCtD
Nefazodone—Convulsion—Methotrexate—psoriatic arthritis	0.000279	0.000856	CcSEcCtD
Nefazodone—Dyspepsia—Prednisone—psoriatic arthritis	0.000277	0.000849	CcSEcCtD
Nefazodone—Arthralgia—Methotrexate—psoriatic arthritis	0.000274	0.000841	CcSEcCtD
Nefazodone—Chest pain—Methotrexate—psoriatic arthritis	0.000274	0.000841	CcSEcCtD
Nefazodone—Myalgia—Methotrexate—psoriatic arthritis	0.000274	0.000841	CcSEcCtD
Nefazodone—Decreased appetite—Prednisone—psoriatic arthritis	0.000274	0.000838	CcSEcCtD
Nefazodone—Rash—Prednisolone—psoriatic arthritis	0.000273	0.000837	CcSEcCtD
Nefazodone—Dermatitis—Prednisolone—psoriatic arthritis	0.000273	0.000836	CcSEcCtD
Nefazodone—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000272	0.000833	CcSEcCtD
Nefazodone—Headache—Prednisolone—psoriatic arthritis	0.000271	0.000831	CcSEcCtD
Nefazodone—Discomfort—Methotrexate—psoriatic arthritis	0.000271	0.000831	CcSEcCtD
Nefazodone—Constipation—Prednisone—psoriatic arthritis	0.000269	0.000825	CcSEcCtD
Nefazodone—Confusional state—Methotrexate—psoriatic arthritis	0.000265	0.000813	CcSEcCtD
Nefazodone—Dizziness—Triamcinolone—psoriatic arthritis	0.000263	0.000807	CcSEcCtD
Nefazodone—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000263	0.000806	CcSEcCtD
Nefazodone—Dizziness—Methylprednisolone—psoriatic arthritis	0.000263	0.000805	CcSEcCtD
Nefazodone—Infection—Methotrexate—psoriatic arthritis	0.000261	0.000801	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisone—psoriatic arthritis	0.000259	0.000795	CcSEcCtD
Nefazodone—Asthenia—Betamethasone—psoriatic arthritis	0.000259	0.000794	CcSEcCtD
Nefazodone—Asthenia—Dexamethasone—psoriatic arthritis	0.000259	0.000794	CcSEcCtD
Nefazodone—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000257	0.000789	CcSEcCtD
Nefazodone—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000257	0.000789	CcSEcCtD
Nefazodone—Nausea—Prednisolone—psoriatic arthritis	0.000257	0.000788	CcSEcCtD
Nefazodone—Pruritus—Betamethasone—psoriatic arthritis	0.000256	0.000783	CcSEcCtD
Nefazodone—Pruritus—Dexamethasone—psoriatic arthritis	0.000256	0.000783	CcSEcCtD
Nefazodone—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000254	0.000779	CcSEcCtD
Nefazodone—Vomiting—Triamcinolone—psoriatic arthritis	0.000253	0.000776	CcSEcCtD
Nefazodone—Vomiting—Methylprednisolone—psoriatic arthritis	0.000253	0.000774	CcSEcCtD
Nefazodone—Rash—Triamcinolone—psoriatic arthritis	0.000251	0.000769	CcSEcCtD
Nefazodone—Dermatitis—Triamcinolone—psoriatic arthritis	0.000251	0.000769	CcSEcCtD
Nefazodone—Anorexia—Methotrexate—psoriatic arthritis	0.000251	0.000768	CcSEcCtD
Nefazodone—Rash—Methylprednisolone—psoriatic arthritis	0.000251	0.000768	CcSEcCtD
Nefazodone—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00025	0.000767	CcSEcCtD
Nefazodone—Urticaria—Prednisone—psoriatic arthritis	0.00025	0.000766	CcSEcCtD
Nefazodone—Headache—Triamcinolone—psoriatic arthritis	0.000249	0.000765	CcSEcCtD
Nefazodone—Headache—Methylprednisolone—psoriatic arthritis	0.000249	0.000763	CcSEcCtD
Nefazodone—Body temperature increased—Prednisone—psoriatic arthritis	0.000249	0.000762	CcSEcCtD
Nefazodone—Abdominal pain—Prednisone—psoriatic arthritis	0.000249	0.000762	CcSEcCtD
Nefazodone—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000247	0.000758	CcSEcCtD
Nefazodone—Diarrhoea—Betamethasone—psoriatic arthritis	0.000247	0.000758	CcSEcCtD
Nefazodone—Hypotension—Methotrexate—psoriatic arthritis	0.000246	0.000753	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00024	0.000734	CcSEcCtD
Nefazodone—Dizziness—Betamethasone—psoriatic arthritis	0.000239	0.000732	CcSEcCtD
Nefazodone—Dizziness—Dexamethasone—psoriatic arthritis	0.000239	0.000732	CcSEcCtD
Nefazodone—Insomnia—Methotrexate—psoriatic arthritis	0.000238	0.000729	CcSEcCtD
Nefazodone—Nausea—Triamcinolone—psoriatic arthritis	0.000237	0.000725	CcSEcCtD
Nefazodone—Paraesthesia—Methotrexate—psoriatic arthritis	0.000236	0.000724	CcSEcCtD
Nefazodone—Nausea—Methylprednisolone—psoriatic arthritis	0.000236	0.000723	CcSEcCtD
Nefazodone—Dyspnoea—Methotrexate—psoriatic arthritis	0.000234	0.000719	CcSEcCtD
Nefazodone—Somnolence—Methotrexate—psoriatic arthritis	0.000234	0.000716	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisone—psoriatic arthritis	0.000232	0.00071	CcSEcCtD
Nefazodone—Dyspepsia—Methotrexate—psoriatic arthritis	0.000232	0.000709	CcSEcCtD
Nefazodone—Vomiting—Betamethasone—psoriatic arthritis	0.00023	0.000704	CcSEcCtD
Nefazodone—Vomiting—Dexamethasone—psoriatic arthritis	0.00023	0.000704	CcSEcCtD
Nefazodone—Decreased appetite—Methotrexate—psoriatic arthritis	0.000229	0.000701	CcSEcCtD
Nefazodone—Rash—Dexamethasone—psoriatic arthritis	0.000228	0.000698	CcSEcCtD
Nefazodone—Rash—Betamethasone—psoriatic arthritis	0.000228	0.000698	CcSEcCtD
Nefazodone—Dermatitis—Betamethasone—psoriatic arthritis	0.000228	0.000698	CcSEcCtD
Nefazodone—Dermatitis—Dexamethasone—psoriatic arthritis	0.000228	0.000698	CcSEcCtD
Nefazodone—Headache—Dexamethasone—psoriatic arthritis	0.000226	0.000694	CcSEcCtD
Nefazodone—Headache—Betamethasone—psoriatic arthritis	0.000226	0.000694	CcSEcCtD
Nefazodone—Asthenia—Prednisone—psoriatic arthritis	0.000226	0.000692	CcSEcCtD
Nefazodone—Pain—Methotrexate—psoriatic arthritis	0.000225	0.000689	CcSEcCtD
Nefazodone—Pruritus—Prednisone—psoriatic arthritis	0.000223	0.000682	CcSEcCtD
Nefazodone—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000217	0.000664	CcSEcCtD
Nefazodone—Diarrhoea—Prednisone—psoriatic arthritis	0.000215	0.00066	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000215	0.000659	CcSEcCtD
Nefazodone—Nausea—Betamethasone—psoriatic arthritis	0.000215	0.000658	CcSEcCtD
Nefazodone—Nausea—Dexamethasone—psoriatic arthritis	0.000215	0.000658	CcSEcCtD
Nefazodone—Urticaria—Methotrexate—psoriatic arthritis	0.000209	0.00064	CcSEcCtD
Nefazodone—Dizziness—Prednisone—psoriatic arthritis	0.000208	0.000638	CcSEcCtD
Nefazodone—Abdominal pain—Methotrexate—psoriatic arthritis	0.000208	0.000637	CcSEcCtD
Nefazodone—Body temperature increased—Methotrexate—psoriatic arthritis	0.000208	0.000637	CcSEcCtD
Nefazodone—Vomiting—Prednisone—psoriatic arthritis	0.0002	0.000613	CcSEcCtD
Nefazodone—Rash—Prednisone—psoriatic arthritis	0.000198	0.000608	CcSEcCtD
Nefazodone—Dermatitis—Prednisone—psoriatic arthritis	0.000198	0.000607	CcSEcCtD
Nefazodone—Headache—Prednisone—psoriatic arthritis	0.000197	0.000604	CcSEcCtD
Nefazodone—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000194	0.000594	CcSEcCtD
Nefazodone—Asthenia—Methotrexate—psoriatic arthritis	0.000189	0.000578	CcSEcCtD
Nefazodone—Nausea—Prednisone—psoriatic arthritis	0.000187	0.000573	CcSEcCtD
Nefazodone—Pruritus—Methotrexate—psoriatic arthritis	0.000186	0.00057	CcSEcCtD
Nefazodone—Diarrhoea—Methotrexate—psoriatic arthritis	0.00018	0.000551	CcSEcCtD
Nefazodone—Dizziness—Methotrexate—psoriatic arthritis	0.000174	0.000533	CcSEcCtD
Nefazodone—Vomiting—Methotrexate—psoriatic arthritis	0.000167	0.000512	CcSEcCtD
Nefazodone—Rash—Methotrexate—psoriatic arthritis	0.000166	0.000508	CcSEcCtD
Nefazodone—Dermatitis—Methotrexate—psoriatic arthritis	0.000166	0.000508	CcSEcCtD
Nefazodone—Headache—Methotrexate—psoriatic arthritis	0.000165	0.000505	CcSEcCtD
Nefazodone—Nausea—Methotrexate—psoriatic arthritis	0.000156	0.000479	CcSEcCtD
